Tao Jia

127 West Changle Road
Xi'an, 710032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

MRGPRX2-Mediated Mast Cell Activation Promotes Malignant Progression of Cutaneous Squamous Cell Carcinoma through IL-17A Release.

MRGPRX2-Mediated Mast Cell Activation Promotes Malignant Progression of Cutaneous Squamous Cell Carcinoma through IL-17A Release.

Journal: The Journal of investigative dermatology

Published: June 01, 2025

Isoxanthohumol inhibits MRGPRX2-mediated mast cell activation reducing inflammation in rosacea.

Isoxanthohumol inhibits MRGPRX2-mediated mast cell activation reducing inflammation in rosacea.

Journal: Chinese medical journal

Published: February 09, 2025

Global research trends in perioperative care for diabetic patients: a bibliometric and visualized study.

Global research trends in perioperative care for diabetic patients: a bibliometric and visualized study.

Journal: Perioperative medicine (London, England)

Published: January 04, 2025

Investigating the potential role of EIF2S2 in OSCC progression through comprehensive bioinformatics analysis and experimental validation.

Investigating the potential role of EIF2S2 in OSCC progression through comprehensive bioinformatics analysis and experimental validation.

Journal: European journal of medical research

Published: December 24, 2024

Casticin reduces rosacea-related inflammation by inhibiting mast cell activation via Mas-related G protein-coupled receptor X2.

Casticin reduces rosacea-related inflammation by inhibiting mast cell activation via Mas-related G protein-coupled receptor X2.

Journal: Inflammopharmacology

Published: December 09, 2024

Systemic administration of Neochamaejasmin B inhibits mast cell activation to reduce inflammation in a rosacea mouse model by targeting MRGPRX2.

Systemic administration of Neochamaejasmin B inhibits mast cell activation to reduce inflammation in a rosacea mouse model by targeting MRGPRX2.

Journal: European journal of pharmacology

Published: November 25, 2024

Corrigendum to "Decreased TET2/5-hmC reduces the integrity of the epidermal barrier via epigenetic dysregulation of filaggrin in psoriatic lesions" [J. Dermatol. Sci. 113 (2024) 103-112].

Corrigendum to "Decreased TET2/5-hmC reduces the integrity of the epidermal barrier via epigenetic dysregulation of filaggrin in psoriatic lesions" [J. Dermatol. Sci. 113 (2024) 103-112].

Journal: Journal of dermatological science

Published: August 02, 2024

Corrigendum to "Dual effect of tacrolimus on mast cell-mediated allergy and inflammation through MAS-related G protein-coupled receptor-X2" [J. Dermatol. Sci. 112 (2023) 128-137].

Corrigendum to "Dual effect of tacrolimus on mast cell-mediated allergy and inflammation through MAS-related G protein-coupled receptor-X2" [J. Dermatol. Sci. 112 (2023) 128-137].

Journal: Journal of dermatological science

Published: July 31, 2024

Corrigendum to "p-Phenylenediamine induces immediate contact allergy and non-histaminergic itch via MRGPRX2" [Chem. Biol. Interact. 351 (2022):109751].

Corrigendum to "p-Phenylenediamine induces immediate contact allergy and non-histaminergic itch via MRGPRX2" [Chem. Biol. Interact. 351 (2022):109751].

Journal: Chemico-biological interactions

Published: May 30, 2024

Association Between Loop Diuretics and Mortality in Patients With Cardiac Surgery-Associated Acute Kidney Injury: A Retrospective Propensity Score-Weighted Analysis.

Association Between Loop Diuretics and Mortality in Patients With Cardiac Surgery-Associated Acute Kidney Injury: A Retrospective Propensity Score-Weighted Analysis.

Journal: Anesthesia and analgesia

Published: November 27, 2023

Decreased TET2/5-hmC reduces the integrity of the epidermal barrier via epigenetic dysregulation of filaggrin in psoriatic lesions.

Decreased TET2/5-hmC reduces the integrity of the epidermal barrier via epigenetic dysregulation of filaggrin in psoriatic lesions.

Journal: Journal of dermatological science

Published: October 06, 2023

Preliminary studies on the role of mast cells in the phenotype and immune activation of type 2 inflammatory cytokine release of atopic dermatitis

Preliminary studies on the role of mast cells in the phenotype and immune activation of type 2 inflammatory cytokine release of atopic dermatitis

Journal: Zhonghua yi xue za zhi

Published: August 31, 2023

Showing 1-12 of 22

Last Updated: 09/26/2026